Publication date: 15 August 2017
Source:Bioorganic & Medicinal Chemistry, Volume 25, Issue 16
Author(s): Hitomi Yuki, Ko Kikuzato, Yasuko Koda, Junko Mikuni, Yuri Tomabechi, Mutsuko Kukimoto-Niino, Akiko Tanaka, Fumiyuki Shirai, Mikako Shirouzu, Hiroo Koyama, Teruki Honma
We previously reported the structure-based design of a highly potent hematopoietic cell kinase (HCK) inhibitor, a pyrrolo-pyrimidine compound designated RK-20449, for treatment of recurrent leukemia. Herein we report the synthesis and structure–activity relationships of some amino acid derivatives of 7-substituted pyrrolo-pyrimidine. Although these derivatives had the same predicted binding conformation as RK-20449, their IC50 values were 100–1000 times larger than that of the parent compound. We assumed that the basicity of the amine nitrogen, which formed an ionic bond with Asp348 of HCK, markedly affected inhibitory activity against HCK. The pKa values of the nitrogen were predicted by means of an ab initio quantum mechanical method, and complexes of the derivatives with HCK were analyzed by X-ray crystallography. We observed a significant correlation between the predicted pKa and IC50 values, and the crystal structures of the less potent derivatives showed various types of defects around the ionic bond.
Graphical abstract
http://ift.tt/2tiIu1t
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου